Advertisement
The leading life science news channel in the Nordic region.
Clinical Trials - December 3, 2024
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment.
In a new job - December 2, 2024
Professor Ylva Engström was recently re-elected as Chair of the Board of Science for Life Laboratory (SciLifeLab) and NLS asked her about her career, her efforts, and her advice to other women in life science.
Intellectual Property - December 2, 2024
The company has been granted a US patent for its SiPore platform technology.
Agreement - December 2, 2024
The two companies have decided to terminate the partnership agreement, covering the rights for Orexo to commercialize the digital mental health program for depression, Deprexis, in the US.
Commentary - December 2, 2024
In today’s rapidly shifting global landscape, it’s clear that the future of humanity hinges on how we invest in people, particularly leaders, right now.
Uncategorized - December 1, 2024
Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.
New Market - November 29, 2024
ScandiDos has announced that the prestigious Hospital Central de la Defensa Gómez Ulla (HCD Gómez Ulla) in Madrid has become a reference center for ScandiDos and the Delta4 family of products.
Intellectual Property - November 27, 2024
Abera Bioscience has received the final decision to approve its patent application “Display of heterologous molecules on bacterial cells and membrane vesicles” from the European Patent Office (EPO).
Biotech article - November 26, 2024
Anocca has announced the submission of its first Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for a Phase I/II multi-asset umbrella trial, VIDAR-1.
Biotech Business - November 26, 2024
The rightsizing is expected to result in redundancy of approximately 20 percent of the employees across the CELLINK organization.
This site uses cookies